Logo Image
|Podcasts|November 19, 2021

What lies ahead for vaccines

Contemporary Pediatrics sat down with editor-in-chief Dr. Tina Q. Tan to discuss the authorization of the Pfizer/BioNTech vaccine for use in many children as well as what lies ahead in the vaccine pipeline for the pediatric population.

The news about the Pfizer/BioNTech COVID-19 vaccine becoming available for children aged 5 to 11 years was met with happiness by pediatricians and many parents alike. Vaccines in the pipeline could bring similar happiness if found safe and effective.

Contemporary Pediatrics sat down with editor-in-chief Dr. Tina Q. Tan to discuss the authorization of the Pfizer/BioNTech vaccine for use in many children as well as what lies ahead in the vaccine pipeline for the pediatric population.

Related Content

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update
Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

View more